نتائج البحث - Theodore W. Laetsch

تنقيح النتائج
  1. 1
    Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer

    Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer حسب Theodore W. Laetsch, David S. Hong

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Opportunities and Challenges in Drug Development for Pediatric Cancers

    Opportunities and Challenges in Drug Development for Pediatric Cancers حسب Theodore W. Laetsch, Steven G. DuBois, Julia Glade Bender, Margaret E. Macy, Lucas Moreno

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial

    Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial حسب Carl E. Allen, Theodore W. Laetsch, Rajen Mody, Meredith S. Irwin, Megan S. Lim, Peter C. Adamson, Nita L. Seibel, D. Williams Parsons, Y. Jae Cho, Katherine A. Janeway

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies

    Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies حسب Daniel Orbach, Monika Sparber‐Sauer, Theodore W. Laetsch, Véronique Minard‐Colin, Stefan Bielack, Michela Casanova, Nadège Corradini, Ewa Kościelniak, Monika Scheer, Simone Hettmer, Gianni Bisogno, Douglas S. Hawkins, Andrea Ferrari

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Molecular landscape and therapeutic strategies in pediatric differentiated thyroid carcinoma

    Molecular landscape and therapeutic strategies in pediatric differentiated thyroid carcinoma حسب Adeline Yang, T. Lai, Theodore W. Laetsch, Tricia R. Bhatti, Zubair Baloch, Lea F. Surrey, Aime T. Franco, Julio C. Ricarte‐Filho, Sogol Mostoufi‐Moab, N. Scott Adzick, Ken Kazahaya, Andrew J. Bauer

    منشور في 2025
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy

    Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy حسب Jochen Buechner, Stephan A. Grupp, Hidefumi Hiramatsu, David T. Teachey, Susana Rives, Theodore W. Laetsch, Gregory A. Yanik, Patricia A. Wood, Rakesh Awasthi, Lan Yi, Andrea Chassot-Agostinho, Lamis Eldjerou, Barbara De Moerloose

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas

    The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas حسب Steven G. DuBois, Theodore W. Laetsch, Noah Federman, Brian Turpin, Catherine M. Albert, Ramamoorthy Nagasubramanian, Megan E. Anderson, Jessica L. Davis, Hope Qamoos, Mark Reynolds, Scott Cruickshank, Michael C. Cox, Douglas S. Hawkins, Leo Mascarenhas, Alberto S. Pappo

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers

    Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers حسب Aime T. Franco, Julio C. Ricarte‐Filho, Amber Isaza, Zachary Jones, N. Jain, Sogol Mostoufi‐Moab, Lea F. Surrey, Theodore W. Laetsch, Marilyn M. Li, Jessica Clague DeHart, Erin R. Reichenberger, Deanne Taylor, Ken Kazahaya, N. Scott Adzick, Andrew J. Bauer

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells

    Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells حسب Andrew M. Stein, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Bruce L. Levine, Lori Tomassian, Sweta Shah, Mimi Leung, Pai‐Hsi Huang, Rakesh Awasthi, Karen Thudium Mueller, Patricia A. Wood, Carl H. June

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

    Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression حسب Nicholas F. Evageliou, Michelle Haber, Annette Vu, Theodore W. Laetsch, Jayne Murray, Laura D. Gamble, Ngan Ching Cheng, Kangning Liu, Megan Reese, Kelly A. Corrigan, David S. Ziegler, Hannah Webber, Candice S. Hayes, Bruce Pawel, Glenn M. Marshall, Huaqing Zhao, Susan K. Gilmour, Murray D. Norris, Michael D. Hogarty

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

    Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study حسب Theodore W. Laetsch, Steven G. DuBois, Leo Mascarenhas, Brian Turpin, Noah Federman, Catherine M. Albert, Ramamoorthy Nagasubramanian, Jessica L. Davis, Erin R. Rudzinski, Angela M. Feraco, Brian B. Tuch, Kevin Ebata, Mark Reynolds, Steven G. Smith, Scott Cruickshank, Michael C. Cox, Alberto S. Pappo, Douglas S. Hawkins

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells

    Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells حسب Haneen Shalabi, Juliane Gust, Agne Taraseviciute, Pamela L. Wolters, Allison Barz Leahy, Carlos Sandi, Theodore W. Laetsch, Lori Wiener, Rebecca Gardner, Véronique Nussenblatt, Joshua A. Hill, Kevin J. Curran, Timothy S. Olson, Colleen Annesley, Hao‐Wei Wang, Javed Khan, Marcelo C. Pasquini, Christine Duncan, Stephan A. Grupp, Michael A. Pulsipher, Nirali N. Shah

    منشور في 2021
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia

    Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia حسب Karen Thudium Mueller, Edward Waldron, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Jason S. Hamilton, Rakesh Awasthi, Andrew M. Stein, Denise Sickert, Abhijit Chakraborty, Bruce L. Levine, Carl H. June, Lori Tomassian, Sweta Shah, Mimi Leung, Tetiana Taran, Patricia A. Wood, Shannon L. Maude

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

    Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia حسب Michael A. Pulsipher, Xia Han, Shannon L. Maude, Theodore W. Laetsch, Muna Qayed, Susana Rives, Michael W. Boyer, Hidefumi Hiramatsu, Gregory A. Yanik, Tim Driscoll, Gary D. Myers, Peter Bader, André Baruchel, Jochen Buechner, Heather E. Stefanski, Creton Kalfoglou, Kevin T. Nguyen, Edward R. Waldron, Karen Thudium Mueller, Harald J. Maier, Gabor Kari, Stephan A. Grupp

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor

    DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor حسب Junne Kamihara, Vera Paulson, Micheál Breen, Theodore W. Laetsch, Dinesh Rakheja, David S. Shulman, Michelle Long Schoettler, Catherine Clinton, Abigail Ward, Deirdre Reidy, R. Seth Pinches, Daniel A. Weiser, Elizabeth A. Mullen, Jaclyn Schienda, Paul A. Meyers, Steven G. DuBois, Jonathan A. Nowak, William D. Foulkes, Kris Ann P. Schultz, Katherine A. Janeway, Sara O. Vargas, Alanna J. Church

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial

    Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm... حسب Theodore W. Laetsch, Gary Douglas Myers, André Baruchel, Andrew C. Dietz, Michael A. Pulsipher, Henrique Bittencourt, Jochen Buechner, Barbara De Moerloose, Kara L. Davis, Eneida R. Nemecek, Timothy Driscoll, Françoise Méchinaud, Nicolas Boissel, Susana Rives, Peter Bader, Christina Peters, Himalee S. Sabnis, Stephan A. Grupp, Gregory A. Yanik, Hidefumi Hiramatsu, Heather E. Stefanski, Lawrence Rasouliyan, Lan Yi, Sweta Shah, Jie Zhang, Andrew C. Harris

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy

    Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy حسب Emily M. Hsieh, Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M. Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W. Lee, Amanda M. DiNofia, Stephan A. Grupp, Michael R. Verneris, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca Gardner, Lia Gore, Nirali N. Shah, Adam J. Lamble

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

    Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial حسب Theodore W. Laetsch, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qayed, Jochen Buechner, Michael A. Pulsipher, Gary Douglas Myers, Heather E. Stefanski, Paul L. Martin, Eneida R. Nemecek, Christina Peters, Gregory A. Yanik, Seong Lin Khaw, Kara L. Davis, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Ranjan Tiwari, Darragh O’Donovan, Stephan A. Grupp

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial

    Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial حسب Stephan A. Grupp, Shannon L. Maude, Susana Rives, André Baruchel, Michael Boyer, Henrique Bittencourt, Peter Bader, Jochen Büchner, Theodore W. Laetsch, Heather E. Stefanski, Gary Douglas Myers, Muna Qayed, Michael A. Pulsipher, Barbara De Moerloose, Gregory A. Yanik, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Christina Peters, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Françoise Méchinaud, Mimi Leung, Lamis Eldjerou, Eric Bleickardt, Karen Thudium Mueller, Hidefumi Hiramatsu

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

    Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma حسب Vinod Pullarkat, Norman J. Lacayo, Elias Jabbour, Jeffrey E. Rubnitz, Ashish Bajel, Theodore W. Laetsch, Jessica T. Leonard, Susan I. Colace, Seong Lin Khaw, Shaun Fleming, Ryan J. Mattison, Robin E. Norris, Joseph T. Opferman, Kathryn G. Roberts, Yaqi Zhao, Chunxu Qu, Mohamed Badawi, Michelle Schmidt, Bo Tong, John C. Pesko, Yan Sun, Jeremy A. Ross, Deeksha Vishwamitra, Lindsey Rosenwinkel, Su Young Kim, Amanda Jacobson, Charles G. Mullighan, Thomas Alexander, Wendy Stock

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: